Page last updated: 2024-09-04

butyryl-n-trihexylcitrate and Cancer of Kidney

butyryl-n-trihexylcitrate has been researched along with Cancer of Kidney in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
de Korte, D; den Besten, G; Go, M; Gouwerok, E; Janssen, M; Klei, TRL; Lagerberg, JW; Schipperus, MR; Spelmink, SE; van den Bos, AG; Vermeulen, C; Vlaar, R1

Other Studies

1 other study(ies) available for butyryl-n-trihexylcitrate and Cancer of Kidney

ArticleYear
Clinical and in vitro evaluation of red blood cells collected and stored in a non-DEHP plasticized bag system.
    Vox sanguinis, 2022, Volume: 117, Issue:10

    Topics: Adenine; Blood Preservation; Butyrates; Carcinoma, Renal Cell; Diethylhexyl Phthalate; Erythrocytes; Glucose; Guanosine; Hemolysis; Humans; Kidney Neoplasms; Mannitol; Phosphates; Plasticizers; Polyvinyl Chloride; Sodium Chloride; Transfusion Reaction

2022